Proton pump inhibitor use is not associated with cardiac arrhythmia in critically ill patients

E-ISSN： 1552-4604|55|7|774-779

ISSN： 0091-2700

Source： JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.55, Iss.7, 2015-07, pp. : 774-779

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Levetiracetam use in critically ill patients

By Szaflarski Jerzy Meckler Jason Szaflarski Magdalena Shutter Lori Privitera Michael Yates Stephen

Neurocritical Care, Vol. 7, Iss. 2, 2007-10 ,pp. : 140-147

Humana Press, Inc

Access to resources Recommend Favorite

Letter: proton pump inhibitor use and fracture risk

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 3, 2018-02 ,pp. : 449-450

John Wiley & Sons Inc

Access to resources Recommend Favorite

Proton‐Pump Inhibitor use and the risk of Ischaemic Stroke

JOURNAL OF INTERNAL MEDICINE, Vol. 283, Iss. 3, 2018-03 ,pp. : 330-330

John Wiley & Sons Inc

Access to resources Recommend Favorite

Outbreak of gastric mucormycosis associated with the use of wooden tongue depressors in critically ill patients

By Maraví-Poma Enrique Rodríguez-Tudela Juan Jalón Jesús Manrique-Larralde Alfonso Torroba Luis Urtasun Jesús Salvador Blanca Montes Marta Mellado Emilia Rodríguez-Albarrán Fernando Pueyo-Royo Antonio

Intensive Care Medicine, Vol. 30, Iss. 4, 2004-04 ,pp. : 724-728

Springer Publishing Company

Access to resources Recommend Favorite

Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 5, 2015-03 ,pp. : 459-466

John Wiley & Sons Inc

Access to resources Recommend Favorite